Results 201 to 210 of about 229,435 (354)

Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy

iMetaOmics, EarlyView.
This study investigates the risk of thrombotic microangiopathy (TMA) induced by vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) inhibitors in cancer therapy. Using data from the FDA Adverse Event Reporting System (FAERS), the WHO Global Database for Adverse Drug Reactions (Vigibase), and The Cancer ...
Aimin Jiang, Zhanzhi Li, Ying Liu, Junyi Shen, Quan Cheng, Anqi Lin, Peng Luo, Linhui Wang   +7 more
wiley   +1 more source

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification. [PDF]

BJC Rep
Yoshimura T, Nakamura K, Chiyoda T, Takamatsu R, Kawano R, Aimono E, Kawaida M, Sakai K, Masugi Y, Nishihara H, Yamagami W.   +10 more
europepmc   +1 more source

Association between prophylactic antibiotics for endometrial biopsy and the incidence of pelvic inflammatory disease: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Risa Ishida, Yusuke Sasabuchi, Kaori Koga, Gentaro Izumi, Daisuke Shigemi, Hiroki Matsui, Hideo Yasunaga, Yutaka Osuga   +7 more
wiley   +1 more source

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

Navigating complexities of polymorphic microbiomes in endometrial cancer. [PDF]

NPJ Biofilms Microbiomes
Jimenez NR, Herman CR, Łaniewski P, Cope E, Lee K, Mahnert ND, Chase DM, Caporaso JG, Herbst-Kralovetz MM.   +8 more
europepmc   +1 more source

Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy [PDF]

, 1995
Carmel J. Cohen, Jamal Rahaman
openalex   +1 more source

Research and scholarly methods: Mitigating information bias

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
Abstract Whether designing a research study or considering changes to a patient's medication therapy based on published research, pharmacists must be knowledgeable about potential sources of bias in clinical research and how these threats to internal validity can be mitigated.
Gary L. Cochran, Hannah C. Cochran, Michael E. Ernst   +2 more
wiley   +1 more source

Analysis of Risk Factors for Secondary Endometrial Cancer-Related Death: A SEER-Based Study

International Journal of Women's Health
Lianjie Miao, Songwei Feng, Bo Ding, Ke Zhang, Yue Ding, Yang Shen Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of ChinaCorrespondence: Yang Shen, Department of Obstetrics
Miao L, Feng S, Ding B, Zhang K, Ding Y, Shen Y   +5 more
doaj  

The microbiome in endometrial cancer: vaginal milieu matters. [PDF]

Front Med (Lausanne)
Govorov I, Komlichenko E, Ulrikh E, Dikareva E, Pervunina T, Vazhenina O, Dzharbaeva A, Kalinina O, Zaikova E, Razumova Z, Mints M, Sitkin S.   +11 more
europepmc   +1 more source

Colorectal cancer in a 13‐year‐old with constitutional mismatch repair deficiency and MUTYH heterozygosity

JPGN Reports, EarlyView.
Abstract Constitutional mismatch repair deficiency (CMMRD) is a rare hereditary cancer syndrome resulting from biallelic mutations in DNA mismatch repair (MMR) genes that lead to early‐onset cancers in children, including lymphoma and colorectal cancer (CRC).
Chloe J. Cohan, Caroline Chinchilla Putzeys, Brianna Pruniski, Paul Tran   +3 more
wiley   +1 more source